Régions
Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Nord-Pas-de-Calais21
Alain Saraux25
Nord-Pas-de-Calais Sauf Alain Saraux" 18
Alain Saraux Sauf Nord-Pas-de-Calais" 22
Nord-Pas-de-Calais Et Alain Saraux 3
Nord-Pas-de-Calais Ou Alain Saraux 43
Corpus6869
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000E47 Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
001E34 Valérie Devauchelle-Pensec [France] ; Jacques-Eric Gottenberg [France] ; Sandrine Jousse-Joulin [France] ; Jean-Marie Berthelot [France] ; Aleth Perdriger [France] ; Eric Hachulla [France] ; Pierre Yves Hatron [France] ; Xavier Puechal [France] ; Véronique Le Guern [France] ; Jean Sibilia [France] ; Laurent Chiche [France] ; Vincent Goeb [France] ; Olivier Vittecoq [France] ; Claire Larroche [France] ; Anne Laure Fauchais [France] ; Gilles Hayem [France] ; Jacques Morel [France] ; Charles Zarnitsky [France] ; Jean Jacques Dubost [France] ; Philippe Dieudé [France] ; Jacques Olivier Pers [France] ; Divi Cornec [France] ; Raphaele Seror [France] ; Xavier Mariette [France] ; Emmanuel Nowak [France] ; Alain Saraux [France]Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome?
004401 Alain Saraux [France] ; Stéphanie Rouanet [France] ; René-Marc Flipo [France] ; Jean-Cyril Poncet [France] ; Patrice Fardellone [France] ; Pascal Hilliquin [France] ; Isabelle Idier [France] ; Alain Cantagrel [France]Glucocorticoid-sparing in patients suffering from rheumatoid arthritis and treated with tocilizumab: the SPARE-1 study.
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021